What is HC Wainwright’s Estimate for EPRX Q2 Earnings?

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Free Report) – Research analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of Eupraxia Pharmaceuticals in a research note issued on Thursday, June 26th. HC Wainwright analyst B. Folkes forecasts that the company will post earnings per share of ($0.21) for the quarter. HC Wainwright has […]

Leave a Reply

Your email address will not be published.

Previous post DA Davidson Issues Pessimistic Forecast for FITB Earnings
Next post What is Lifesci Capital’s Estimate for DBVT Q2 Earnings?